Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-02T19:55:45.364Z.
Calculation as of: 2026-10-02T19:55:45.364Z.
Quote observation: 2026-10-02T19:55:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 054a65786064a73545931b308e74131b250e2c5f6c2462854f5738f681d07736
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$63.17B
EBITDA Yield
7.70%
TTM Avg
5.05%
3Y Avg
3.61%
5Y Avg
3.75%
Market Cap
$49.07B
EBITDA Yield
4.26%
TTM Avg
3.85%
3Y Avg
3.75%
5Y Avg
3.53%
Market Cap
$48.68B
EBITDA Yield
8.50%
TTM Avg
8.02%
3Y Avg
7.16%
5Y Avg
6.82%
Market Cap
$47.49B
EBITDA Yield
3.84%
TTM Avg
4.48%
3Y Avg
4.38%
5Y Avg
4.37%
Market Cap
$45.97B
EBITDA Yield
5.02%
TTM Avg
5.81%
3Y Avg
4.27%
5Y Avg
4.52%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Natera, Inc. (NTRA) | $58.64B | N/A | N/A | N/A | N/A |
| Cencora, Inc. (COR)vs › | $60.25B | 7.79% | 7.09% | 7.40% | 8.37% |
| Boston Scientific Corporation (BSX)vs › | $63.17B | 7.70% | 5.05% | 3.61% | 3.75% |
| Cardinal Health, Inc. (CAH)vs › | $53.70B | 6.07% | 5.95% | 6.52% | 5.89% |
| Edwards Lifesciences Corporation (EW)vs › | $49.07B | 4.26% | 3.85% | 3.75% | 3.53% |
| Becton, Dickinson and Company (BDX)vs › | $48.68B | 8.50% | 8.02% | 7.16% | 6.82% |
| Agilent Technologies, Inc. (A)vs › | $47.49B | 3.84% | 4.48% | 4.38% | 4.37% |
| Humana Inc. (HUM)vs › | $46.78B | 5.12% | 6.05% | 7.19% | 7.07% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.97B | 5.02% | 5.81% | 4.27% | 4.52% |
| Cigna Corporation (CI)vs › | $71.56B | 12.71% | 11.97% | 10.83% | 10.47% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2015-08-13 | 1.15% |
| 2015-08-12 | 1.09% |
| 2015-08-11 | 1.07% |
| 2015-08-10 | 1.03% |
| 2015-08-07 | 1.04% |
| 2015-08-06 | 0.99% |
| 2015-08-05 | 1.01% |
| 2015-08-04 | 1.03% |
| 2015-08-03 | 1.05% |
| 2015-07-31 | 0.98% |
| 2015-07-30 | 0.98% |
| 2015-07-29 | 0.97% |
| 2015-07-28 | 0.98% |
| 2015-07-27 | 0.98% |
| 2015-07-24 | 0.92% |
| 2015-07-23 | 0.86% |
| 2015-07-22 | 0.84% |
| 2015-07-21 | 0.85% |
| 2015-07-20 | 0.82% |
| 2015-07-17 | 0.84% |
| 2015-07-16 | 0.80% |
| 2015-07-15 | 0.85% |
| 2015-07-14 | 0.85% |
| 2015-07-13 | 0.83% |
| 2015-07-10 | 0.80% |
| 2015-07-09 | 0.82% |
| 2015-07-08 | 0.81% |
| 2015-07-07 | 0.79% |
| 2015-07-06 | 0.79% |
| 2015-07-02 | 0.77% |
| 2015-07-01 | 0.98% |
